Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome

Author:

González‐Tablas Pimenta María12ORCID,Otero Álvaro13ORCID,Arandia Guzman Daniel Angel13ORCID,Pascual‐Argente Daniel13ORCID,Ruíz Martín Laura13ORCID,Sousa‐Casasnovas Pablo13ORCID,García‐Martin Andoni13ORCID,Roa Montes de Oca Juan Carlos13ORCID,Villaseñor‐Ledezma Javier13ORCID,Torres Carretero Luis13ORCID,Almeida Maria4ORCID,Ortiz Javie15ORCID,Nieto Adelaida16ORCID,Orfao Alberto127ORCID,Tabernero María Dolores127ORCID

Affiliation:

1. Instituto de Investigación Biomédica de Salamanca IBSAL—University Hospital of Salamanca Salamanca Spain

2. Centre for Cancer Research (CIC‐IBMCC; CSIC/USAL; IBSAL) Department of Medicine University of Salamanca Salamanca Spain

3. Neurosurgery Service University Hospital of Salamanca Salamanca Spain

4. Centre for Neuroscience and Cell Biology University of Coimbra Coimbra Portugal

5. Pathology Service University Hospital of Salamanca Salamanca Spain

6. Radiotherapy Service University Hospital of Salamanca Salamanca Spain

7. Biomedical Research Networking Centre on Cancer–CIBERONC (CB16/12/00400) Institute of Health Carlos III Madrid Spain

Publisher

Wiley

Subject

Neurology (clinical),Pathology and Forensic Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3